Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenue
Product sales	$ 830,880	$ 605,799
Licensing revenue	5,000	5,000
Total revenue	835,880	610,799
Cost of product sales	346,129	368,600
Gross profit	489,751	242,199
Operating expenses
Research and development	116,521	158,793
Sales and marketing	73,381	83,308
General and administrative	479,113	454,375
Total  operating expenses	669,015	696,476
Operating loss	(179,264)	(454,277)
Other income (expenses)
Other income	88,272	21
Interest expense	(178,777)	(160,542)
Amortization of deferred financing costs	(27,045)	(15,324)
Loss on disposal of property and equipment	(63)
Total other income (expenses)	(117,613)	(175,845)
Net Loss	$ (296,877)	$ (630,122)
Basic and diluted net loss per common share	$ 0.00	$ (0.01)
Basic and diluted weighted average common shares used to calculate net loss per common share	69,679,854	69,679,854